Las Vegas, NV -- (SBWIRE) -- 10/04/2013 -- EquityObserver.com covers the breadth of the markets, from stocks and bonds to ETFs, options, emerging markets, activities at the Fed and more .EquityObserver.com issues a special report on the following stocks: Avanir Pharmaceuticals Inc (NASDAQ:AVNR), Janus Capital Group Inc (NYSE:JNS), Antares Pharma Inc (NASDAQ:ATRS), ACCO Brands Corporation (NYSE:ACCO)
Avanir Pharmaceuticals Inc (NASDAQ:AVNR) managed to keep its fall at -4.19% on below -normal volume of 2.11M shares. The stock settled at $4.34 after floating in a range of $4.31 to $4.57. Its latest price has reached market capitalization of $631.34 million. Its 52-week range has been $2.07 to $6. AVANIR Pharmaceuticals, Inc. (AVANIR) is a pharmaceutical company focused on developing and commercializing therapeutic products for the treatment of central nervous system disorders.
Has AVNR Found The Bottom and Ready To Move Up? Find Out Here
Janus Capital Group Inc (NYSE:JNS) traded down on a volume of 2.10 million, higher than its standard daily volume. Shares have dropped-0.92% to $8.64. Over the last twelve months, the stock has lost-8.47% and faced a worst price of $7.68. Janus Capital Group Inc., and its subsidiaries (JCG) provide investment management, administration, distribution and related services to financial advisors, individuals and institutional clients through mutual funds, other pooled investment vehicles, separate accounts and sub advised relationships (collectively referred to as investment products) in both domestic and international markets.
Has JNS Found The Bottom And Ready To Gain Momentum? Find Out Here
Antares Pharma Inc (NASDAQ:ATRS) settled 4.09% higher at $4.45 on above-normal volume of 2.09M shares during the last trading day. The stock has its 12-month high at $4.67 and 52-week low price was $3.35. It traded in a range of $4.25 to $4.47 during the last trading day. Antares Pharma, Inc. (Antares) is a pharma company that focuses on self-injection pharmaceutical products and technologies and topical gel-based products.
Why Should Investors Buy ATRS After the Recent Fall? Just Go Here and Find Out
In the last trading session, ACCO Brands Corporation (NYSE:ACCO) was up on high volume, trading at a volume of 2.08 M versus its average daily volume of 572,111.00 shares. At $6.70, the stock has attained market capitalization of 761.26 million. ACCO Brands Corporation is one of the suppliers of branded school and office products. The Company sells its products through many channels that include the office products resale industry as well as through mass retail distribution and e-tailers.
Will ACCO Continue To Move Higher? Find Out Here
About Equity Observer:
Equity Observer delivers intra-day insights into the equities, tech and investment world. The website is a window into what’s going on in the business world and why.
EquityObserver.com covers the breadth of the markets, from stocks and bonds to ETFs, options, emerging markets, activities at the Fed and more.
The disclaimer is to be read and fully understood before using our site, or joining our email list.
http://www.equityobserver.com/ has a no tolerance spam policy; we will not sell or re-distribute your email to any 3rd party. A If applicable, please also unsubscribe from the newsletter using the link at the bottom of the email if you no longer wish to receive our emails. We only send our newsletters to opt-in members.
PLEASE NOTE WELL: The http://www.equityobserver.com/
Employees and contributors are NOT registered as an Investment Adviser in any jurisdiction whatsoever.
Read Full Disclaimerat: http://www.equityobserver.com/
Copyright © 2005-2013 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)